These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17685756)

  • 1. Dosing of divalproex extended release.
    Feifel D
    J Clin Psychiatry; 2007 Jul; 68(7):1146-7; author reply 1147. PubMed ID: 17685756
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
    Longo LP
    Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and tolerability of divalproex extended release in psychiatric patients.
    Jackson RS; Venkataraman S; Atkins RB; Owens M
    Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid oral loading of extended release divalproex in patients with acute mania.
    Miller BP; Perry W; Moutier CY; Robinson SK; Feifel D
    Gen Hosp Psychiatry; 2005; 27(3):218-21. PubMed ID: 15882770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
    J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ergenyl chronospheres in bipolar disorders].
    Grunze H
    Krankenpfl J; 2005; 43(7-10):213. PubMed ID: 16515285
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal dosing of medications (in bipolar disorder).
    Maguire GA; Phillips G
    J Fam Pract; 2003 Mar; Suppl():S22-5. PubMed ID: 12676081
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose lithium augmentation of divalproex in geriatric mania.
    Goldberg JF; Sacks MH; Kocsis JH
    J Clin Psychiatry; 2000 Apr; 61(4):304. PubMed ID: 10830157
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended release.
    Minirth FB; Neal V
    J Clin Psychopharmacol; 2005 Feb; 25(1):99-101. PubMed ID: 15643111
    [No Abstract]   [Full Text] [Related]  

  • 11. Divalproex versus valproate in patients with bipolar disorder.
    Kablinger AS; Czerwinski WP; Minagar A
    J Clin Psychopharmacol; 2004 Apr; 24(2):231-2. PubMed ID: 15206673
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate: do formulations matter?
    Citrome L
    J Clin Pharm Ther; 2008 Aug; 33(4):457; author reply 458. PubMed ID: 18613865
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.
    Redden L; DelBello M; Wagner KD; Wilens TE; Malhotra S; Wozniak P; Vigna NV; Greco N; Kovacs X; Abi-Saab W; Saltarelli M;
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):83-9. PubMed ID: 19232026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divalproex sodium vs. valproic acid: drug utilization patterns, persistence rates and predictors of hospitalization among VA patients diagnosed with bipolar disorder.
    Iqbal SU; Cunningham F; Lee A; Wang S; Hamed A; Miller DR; Ren X; Kazis L
    J Clin Pharm Ther; 2007 Dec; 32(6):625-32. PubMed ID: 18021341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium.
    Horne RL; Cunanan C
    J Clin Psychopharmacol; 2003 Apr; 23(2):176-81. PubMed ID: 12640219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of divalproex sodium extended release containing regimen in Indian patients with bipolar I disorder in continuation phase: Results of EASED registry.
    Shah N; Reddy MS; Vohra S; Chaudhuri U; Mohanasundaram S
    Asian J Psychiatr; 2016 Apr; 20():32-8. PubMed ID: 27025469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BALANCE trial.
    Fountoulakis KN
    Lancet; 2010 Apr; 375(9723):1343-4; author reply 1344. PubMed ID: 20399972
    [No Abstract]   [Full Text] [Related]  

  • 18. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
    Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
    J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders.
    Centorrino F; Kelleher JP; Berry JM; Salvatore P; Eakin M; Fogarty KV; Fellman V; Baldessarini RJ
    Am J Psychiatry; 2003 Jul; 160(7):1348-50. PubMed ID: 12832255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Banuelos-Arzac C
    J Child Adolesc Psychiatr Nurs; 2008 May; 21(2):68. PubMed ID: 18429835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.